Multiple adverse outcomes
This Research was published in the BMJ on the 17 April 2024 and has been made open access. The paper begins with this summary box: A decade has passed since … Continue reading Multiple adverse outcomes
being and becoming in the world
Material from, or relating to, the British Medical Journal [BMJ]
This Research was published in the BMJ on the 17 April 2024 and has been made open access. The paper begins with this summary box: A decade has passed since … Continue reading Multiple adverse outcomes
The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry: PMCPA … Continue reading Publicly reprimanded
This analysis was published in the BMJ on the 9th July 2024. It has been made open access and can be read in full here. Seven years ago I put … Continue reading Does Frailty need a new name?
This article features in the latest BMJ. It has been made open access and is copied in full below. I campaigned for Scotland to introduce Sunshine legislation. I did so … Continue reading Broken beyond repair
Published 21 May 2024 BMJ 2024;385:e076797 Ravi Gupta, assistant professor of medicine Reshma Ramachandran, assistant professor of medicine Joseph S Ross, professor of medicine and health policy Ravi Gupta and … Continue reading Tackling the excesses of pharmaceutical marketing and promotion
This BMJ Talk Medicine podcast can be listened to here. It was published on 28 March 2023. In this podcast Dr Mark Horowitz gives clear and practical advice. Given the … Continue reading Antidepressant withdrawal with Tony Kendrick and Mark Horowitz
This rapid response by Shirley Nurock was made in response to a BMJ report that the US drug company Biogen is “walking away from its Alzheimer’s drug aducanumab (Aduhelm).” In … Continue reading ‘Left wondering’
This Research was published in the BMJ on the 17 April 2024 and has been made open access. The paper begins with this summary box: A decade has passed since … Continue reading Multiple adverse outcomes